Skip to main content
. 2017 Jul 19;8(5):713–726. doi: 10.1002/jcsm.12213

Table 8.

Cut‐point analysis using the optimized five‐site protocol to identify low lean tissue mass

Variable median (IQR) Low‐risk group (≤ −2.071) Moderate‐risk group (−2.070 to −0.6040) High‐risk group (≥ −0.6039)
Proportion of total cohort, n/N 57/96 (59%) 24/96 (25%) 15/96 (16%)
Proportion of individuals categorized as low lean tissue by DXA, n/N 1/57 (2%) 6/24 (25%) 10/15 (67%)
Age, years 33.0 (24.0–69.5)c 28.0 (22.0–69.0)c 77.0 (63.0–80.0)a , b
Echogenicity, A.U. 33.5 (29.8–36.9)c 38.8 (31.0–43.6)c 47.4 (40.4–55.6)a , b
Men
Four‐site thickness, cm 4.34 (3.57–5.02)c 4.14 (3.62–4.34) 2.66 (2.22–2.79)a
Anterior upper arm thickness, cm 3.64 (3.41–3.92)c 3.21 (3.14–3.50) 2.68 (2.24–2.80)a
Women
Four‐site thickness, cm 3.70 (3.27–4.04)b , c 2.98 (2.55–3.92)a , c 2.30 (1.91–2.47)a , b
Anterior upper arm thickness, cm 2.70 (2.47–2.93)b , c 2.28 (2.16–2.36)a 2.17 (1.94–2.30)a

Log odds: −2.071, sensitivity = 0.9411; specificity = 0.7011, positive likelihood ratio = 3.23, negative likelihood ratio = 0.083. Log odds: −0.6039, sensitivity = 0.5882; specificity = 0.9367, positive likelihood ratio = 9.30, negative likelihood ratio = 0.44. A.U., arbitrary unit; DXA, dual‐energy X‐ray absorptiometry; IQR, interquartile range.

a

Significant difference from low‐risk group.

b

Significant difference from moderate‐risk group.

c

Significant difference from high‐risk group.